Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product ( IQOS ®): a cross-sectional study [version 2; peer review: 2 approved]

Background: Several smoke-free tobacco and/or nicotine-containing products (TNP) have emerged in recent years to support tobacco harm reduction strategies and reduce individual health risks and population harm relative to continued cigarette smoking. This paper describes the nationwide prevalence an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:F1000 research 2022, Vol.10, p.504
Hauptverfasser: Afolalu, Esther F, Langer, Peter, Fischer, Karina, Roulet, Steve, Magnani, Pierpaolo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 504
container_title F1000 research
container_volume 10
creator Afolalu, Esther F
Langer, Peter
Fischer, Karina
Roulet, Steve
Magnani, Pierpaolo
description Background: Several smoke-free tobacco and/or nicotine-containing products (TNP) have emerged in recent years to support tobacco harm reduction strategies and reduce individual health risks and population harm relative to continued cigarette smoking. This paper describes the nationwide prevalence and patterns of TNP use in Japan following the commercialization of one such smoke-free TNP, the heated tobacco product IQOS® (Philip Morris International).   Methods: We analyzed the first annual data (2016-2017) of two repeated cross-sectional surveys conducted in a representative sample of the Japanese general adult (≥20 years of age) population (N = 4,878) and a sample of adult IQOS users (N = 2,000). We assessed the prevalence of current TNP use according to type of product (cigarettes, IQOS, e-cigarettes, and other TNPs) in the general population and patterns of TNP use in the IQOS user sample. Results: The prevalence of current use across all TNP in the sampled general population was 18.5% (95% confidence interval 17.2-19.5%), with 17.5% (16.4-18.6%) for cigarette smoking and 1.8% (1.4-2.2%) for IQOS use. Regarding the distribution of patterns of use in the IQOS user survey, the majority (63.4% [61.2-65.6%]) were exclusive users of IQOS, followed by 20.6% (18.7-22.5%) of individuals who reported dual use of IQOS and cigarettes. Conclusions: In Japan, cigarette smoking remains the most prevalent way of consuming TNP; however, IQOS is being adopted by a growing number of adult Japanese smokers. These findings serve as baseline data for monitoring trends over time in the use and adoption of potential smoke-free TNP in Japan.
doi_str_mv 10.12688/f1000research.52407.2
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9069173</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2671930722</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3852-d8fbeaa059283f659d39a2cedef81d0aa758adc6e6483049484425814a30e95e3</originalsourceid><addsrcrecordid>eNqFkt1qFDEUxwdRbKl9BQl4s73Ybb5mJllBkOJHpVBFvRIJZ5Mz7pTZZJpkVvalfAjxwZzdrYv1xquEc37_H4fDKYqnjM4Yr5Q6bxilNGJCiHY5K7mk9Yw_KI45ldWUScof_vU_Kk5TuhkDVGtR8fpxcSTKkitd8uPi1_uIa-jQWyTgHekhZ4w-kdCQHBZgbdjWz0MkvrUhtx5JH4MbbCZDQtJ68g568GTCKavPCDRjnOQlkg4Gb5dbD5AlQkZ3EP4RTMjlh-uP5OePs_kI2RhSmia0uQ0eOpLy4DbkyxpjGguEPyc9ju5x3ha_zwkn0I-iNbqvT4pHDXQJT-_ek-Lz61efLt5Or67fXF68vJpaoUo-dapZIAAtNVeiqUrthAZu0WGjmKMAdanA2QorqQSVWiopeamYBEFRlyhOihd7bz8sVugs-hyhM31sVxA3JkBr7nd8uzTfwtpoWmlWi1EwuRPEcDtgymbVJotdBx7DkIxgQtJKSrpFn_2D3oQhjntJhlc104LWnI9Utad2y4vYHIZh1Oxuxdy7FbO7FbMNzvfBBuzQ5c0WMgfqP-Hfhy_HLg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2671930722</pqid></control><display><type>article</type><title>Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product ( IQOS ®): a cross-sectional study [version 2; peer review: 2 approved]</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Afolalu, Esther F ; Langer, Peter ; Fischer, Karina ; Roulet, Steve ; Magnani, Pierpaolo</creator><creatorcontrib>Afolalu, Esther F ; Langer, Peter ; Fischer, Karina ; Roulet, Steve ; Magnani, Pierpaolo</creatorcontrib><description>Background: Several smoke-free tobacco and/or nicotine-containing products (TNP) have emerged in recent years to support tobacco harm reduction strategies and reduce individual health risks and population harm relative to continued cigarette smoking. This paper describes the nationwide prevalence and patterns of TNP use in Japan following the commercialization of one such smoke-free TNP, the heated tobacco product IQOS® (Philip Morris International).   Methods: We analyzed the first annual data (2016-2017) of two repeated cross-sectional surveys conducted in a representative sample of the Japanese general adult (≥20 years of age) population (N = 4,878) and a sample of adult IQOS users (N = 2,000). We assessed the prevalence of current TNP use according to type of product (cigarettes, IQOS, e-cigarettes, and other TNPs) in the general population and patterns of TNP use in the IQOS user sample. Results: The prevalence of current use across all TNP in the sampled general population was 18.5% (95% confidence interval 17.2-19.5%), with 17.5% (16.4-18.6%) for cigarette smoking and 1.8% (1.4-2.2%) for IQOS use. Regarding the distribution of patterns of use in the IQOS user survey, the majority (63.4% [61.2-65.6%]) were exclusive users of IQOS, followed by 20.6% (18.7-22.5%) of individuals who reported dual use of IQOS and cigarettes. Conclusions: In Japan, cigarette smoking remains the most prevalent way of consuming TNP; however, IQOS is being adopted by a growing number of adult Japanese smokers. These findings serve as baseline data for monitoring trends over time in the use and adoption of potential smoke-free TNP in Japan.</description><identifier>ISSN: 2046-1402</identifier><identifier>EISSN: 2046-1402</identifier><identifier>DOI: 10.12688/f1000research.52407.2</identifier><identifier>PMID: 35528952</identifier><language>eng</language><publisher>London: Faculty of 1000 Ltd</publisher><subject>Aerosols ; Age ; Cigarette smoking ; Cigarettes ; Consumers ; Cross-sectional studies ; Field study ; Harm reduction ; Households ; Nicotine ; Polls &amp; surveys ; Population ; Questionnaires ; Risk assessment ; Sample size ; Tobacco</subject><ispartof>F1000 research, 2022, Vol.10, p.504</ispartof><rights>Copyright: © 2022 Afolalu EF et al.</rights><rights>Copyright: © 2022 Afolalu EF et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright: © 2022 Afolalu EF et al. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3852-d8fbeaa059283f659d39a2cedef81d0aa758adc6e6483049484425814a30e95e3</citedby><cites>FETCH-LOGICAL-c3852-d8fbeaa059283f659d39a2cedef81d0aa758adc6e6483049484425814a30e95e3</cites><orcidid>0000-0001-8866-4765 ; 0000-0002-2596-8582</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069173/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069173/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,4024,27923,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Afolalu, Esther F</creatorcontrib><creatorcontrib>Langer, Peter</creatorcontrib><creatorcontrib>Fischer, Karina</creatorcontrib><creatorcontrib>Roulet, Steve</creatorcontrib><creatorcontrib>Magnani, Pierpaolo</creatorcontrib><title>Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product ( IQOS ®): a cross-sectional study [version 2; peer review: 2 approved]</title><title>F1000 research</title><description>Background: Several smoke-free tobacco and/or nicotine-containing products (TNP) have emerged in recent years to support tobacco harm reduction strategies and reduce individual health risks and population harm relative to continued cigarette smoking. This paper describes the nationwide prevalence and patterns of TNP use in Japan following the commercialization of one such smoke-free TNP, the heated tobacco product IQOS® (Philip Morris International).   Methods: We analyzed the first annual data (2016-2017) of two repeated cross-sectional surveys conducted in a representative sample of the Japanese general adult (≥20 years of age) population (N = 4,878) and a sample of adult IQOS users (N = 2,000). We assessed the prevalence of current TNP use according to type of product (cigarettes, IQOS, e-cigarettes, and other TNPs) in the general population and patterns of TNP use in the IQOS user sample. Results: The prevalence of current use across all TNP in the sampled general population was 18.5% (95% confidence interval 17.2-19.5%), with 17.5% (16.4-18.6%) for cigarette smoking and 1.8% (1.4-2.2%) for IQOS use. Regarding the distribution of patterns of use in the IQOS user survey, the majority (63.4% [61.2-65.6%]) were exclusive users of IQOS, followed by 20.6% (18.7-22.5%) of individuals who reported dual use of IQOS and cigarettes. Conclusions: In Japan, cigarette smoking remains the most prevalent way of consuming TNP; however, IQOS is being adopted by a growing number of adult Japanese smokers. These findings serve as baseline data for monitoring trends over time in the use and adoption of potential smoke-free TNP in Japan.</description><subject>Aerosols</subject><subject>Age</subject><subject>Cigarette smoking</subject><subject>Cigarettes</subject><subject>Consumers</subject><subject>Cross-sectional studies</subject><subject>Field study</subject><subject>Harm reduction</subject><subject>Households</subject><subject>Nicotine</subject><subject>Polls &amp; surveys</subject><subject>Population</subject><subject>Questionnaires</subject><subject>Risk assessment</subject><subject>Sample size</subject><subject>Tobacco</subject><issn>2046-1402</issn><issn>2046-1402</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkt1qFDEUxwdRbKl9BQl4s73Ybb5mJllBkOJHpVBFvRIJZ5Mz7pTZZJpkVvalfAjxwZzdrYv1xquEc37_H4fDKYqnjM4Yr5Q6bxilNGJCiHY5K7mk9Yw_KI45ldWUScof_vU_Kk5TuhkDVGtR8fpxcSTKkitd8uPi1_uIa-jQWyTgHekhZ4w-kdCQHBZgbdjWz0MkvrUhtx5JH4MbbCZDQtJ68g568GTCKavPCDRjnOQlkg4Gb5dbD5AlQkZ3EP4RTMjlh-uP5OePs_kI2RhSmia0uQ0eOpLy4DbkyxpjGguEPyc9ju5x3ha_zwkn0I-iNbqvT4pHDXQJT-_ek-Lz61efLt5Or67fXF68vJpaoUo-dapZIAAtNVeiqUrthAZu0WGjmKMAdanA2QorqQSVWiopeamYBEFRlyhOihd7bz8sVugs-hyhM31sVxA3JkBr7nd8uzTfwtpoWmlWi1EwuRPEcDtgymbVJotdBx7DkIxgQtJKSrpFn_2D3oQhjntJhlc104LWnI9Utad2y4vYHIZh1Oxuxdy7FbO7FbMNzvfBBuzQ5c0WMgfqP-Hfhy_HLg</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Afolalu, Esther F</creator><creator>Langer, Peter</creator><creator>Fischer, Karina</creator><creator>Roulet, Steve</creator><creator>Magnani, Pierpaolo</creator><general>Faculty of 1000 Ltd</general><general>F1000 Research Limited</general><scope>C-E</scope><scope>CH4</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8866-4765</orcidid><orcidid>https://orcid.org/0000-0002-2596-8582</orcidid></search><sort><creationdate>2022</creationdate><title>Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product ( IQOS ®): a cross-sectional study [version 2; peer review: 2 approved]</title><author>Afolalu, Esther F ; Langer, Peter ; Fischer, Karina ; Roulet, Steve ; Magnani, Pierpaolo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3852-d8fbeaa059283f659d39a2cedef81d0aa758adc6e6483049484425814a30e95e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aerosols</topic><topic>Age</topic><topic>Cigarette smoking</topic><topic>Cigarettes</topic><topic>Consumers</topic><topic>Cross-sectional studies</topic><topic>Field study</topic><topic>Harm reduction</topic><topic>Households</topic><topic>Nicotine</topic><topic>Polls &amp; surveys</topic><topic>Population</topic><topic>Questionnaires</topic><topic>Risk assessment</topic><topic>Sample size</topic><topic>Tobacco</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Afolalu, Esther F</creatorcontrib><creatorcontrib>Langer, Peter</creatorcontrib><creatorcontrib>Fischer, Karina</creatorcontrib><creatorcontrib>Roulet, Steve</creatorcontrib><creatorcontrib>Magnani, Pierpaolo</creatorcontrib><collection>F1000Research</collection><collection>Faculty of 1000</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>F1000 research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Afolalu, Esther F</au><au>Langer, Peter</au><au>Fischer, Karina</au><au>Roulet, Steve</au><au>Magnani, Pierpaolo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product ( IQOS ®): a cross-sectional study [version 2; peer review: 2 approved]</atitle><jtitle>F1000 research</jtitle><date>2022</date><risdate>2022</risdate><volume>10</volume><spage>504</spage><pages>504-</pages><issn>2046-1402</issn><eissn>2046-1402</eissn><abstract>Background: Several smoke-free tobacco and/or nicotine-containing products (TNP) have emerged in recent years to support tobacco harm reduction strategies and reduce individual health risks and population harm relative to continued cigarette smoking. This paper describes the nationwide prevalence and patterns of TNP use in Japan following the commercialization of one such smoke-free TNP, the heated tobacco product IQOS® (Philip Morris International).   Methods: We analyzed the first annual data (2016-2017) of two repeated cross-sectional surveys conducted in a representative sample of the Japanese general adult (≥20 years of age) population (N = 4,878) and a sample of adult IQOS users (N = 2,000). We assessed the prevalence of current TNP use according to type of product (cigarettes, IQOS, e-cigarettes, and other TNPs) in the general population and patterns of TNP use in the IQOS user sample. Results: The prevalence of current use across all TNP in the sampled general population was 18.5% (95% confidence interval 17.2-19.5%), with 17.5% (16.4-18.6%) for cigarette smoking and 1.8% (1.4-2.2%) for IQOS use. Regarding the distribution of patterns of use in the IQOS user survey, the majority (63.4% [61.2-65.6%]) were exclusive users of IQOS, followed by 20.6% (18.7-22.5%) of individuals who reported dual use of IQOS and cigarettes. Conclusions: In Japan, cigarette smoking remains the most prevalent way of consuming TNP; however, IQOS is being adopted by a growing number of adult Japanese smokers. These findings serve as baseline data for monitoring trends over time in the use and adoption of potential smoke-free TNP in Japan.</abstract><cop>London</cop><pub>Faculty of 1000 Ltd</pub><pmid>35528952</pmid><doi>10.12688/f1000research.52407.2</doi><orcidid>https://orcid.org/0000-0001-8866-4765</orcidid><orcidid>https://orcid.org/0000-0002-2596-8582</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2046-1402
ispartof F1000 research, 2022, Vol.10, p.504
issn 2046-1402
2046-1402
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9069173
source DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Aerosols
Age
Cigarette smoking
Cigarettes
Consumers
Cross-sectional studies
Field study
Harm reduction
Households
Nicotine
Polls & surveys
Population
Questionnaires
Risk assessment
Sample size
Tobacco
title Prevalence and patterns of tobacco and/or nicotine product use in Japan (2017) after the launch of a heated tobacco product ( IQOS ®): a cross-sectional study [version 2; peer review: 2 approved]
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T01%3A05%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20and%20patterns%20of%20tobacco%20and/or%20nicotine%20product%20use%20in%20Japan%20(2017)%20after%20the%20launch%20of%20a%20heated%20tobacco%20product%20(%20IQOS%20%C2%AE):%20a%20cross-sectional%20study%20%5Bversion%202;%20peer%20review:%202%20approved%5D&rft.jtitle=F1000%20research&rft.au=Afolalu,%20Esther%20F&rft.date=2022&rft.volume=10&rft.spage=504&rft.pages=504-&rft.issn=2046-1402&rft.eissn=2046-1402&rft_id=info:doi/10.12688/f1000research.52407.2&rft_dat=%3Cproquest_pubme%3E2671930722%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2671930722&rft_id=info:pmid/35528952&rfr_iscdi=true